HOME >> BIOLOGY >> NEWS
Pall filtration technology verified to remove arsenic from drinking water

1,300 non-community water systems will need to take measures to lower arsenic in their drinking water.

Membrane filtration technology is emerging as the technology of choice for safe drinking water. Large and small communities around the world currently use the Pall Aria System to remove parasites, including cryptosporidia and giardia cysts and oocysts that can contaminate drinking water and adversely affect public health. The new verification enables these communities to remove both arsenic and parasites cost efficiently. The Pall system is also employed by a wide range of industries to clean up wastewater to prevent additional arsenic from entering the drinking water supply.

Unlike other methods of arsenic removal, such as reverse osmosis and adsorption media, membrane filtration offers a less costly and long-term solution. It does not require a major upfront capital investment, high costs to operate or frequent regeneration and purchase of media. The Pall Aria System works by the addition of an iron-based coagulant, such as ferric chloride, to the water. The contaminating arsenic is adsorbed onto positively charged ferric hydroxide particles, which are then removed by microfiltration.

"The arsenic removal verification opens up a whole new market for Pall Water Processing, which is currently one of the fastest growing businesses of Pall Corporation. This past year our sales to municipal and community water systems have grown over 26 percent," adds Mr. Seibert.

Arsenic Hot Spots and Public Health Implications

Arsenic levels across the U.S. can vary greatly. Although there are some geographic hot spots, the highest arsenic levels in the U.S. are found mostly in states west of the continental divide. However, several New England states such as New Hampshire and Maine have reported that as many as 30% and 14%, respectively, of their public water systems have arsenic levels above the new standard.

Arse
'"/>

Contact: Marcia Katz
Marcia_Katz@pall.com
516-801-9128
Pall Corporation
6-Dec-2005


Page: 1 2 3

Related biology news :

1. Carbon capture, water filtration, other boreal forest ecoservices worth estimated $250 billion/year
2. Water filtration technique removes dangerous freshwater algae toxins
3. Pall blood filtration technology removes prions that can cause TSEs
4. AFCYBER holds science and technology symposium
5. New technology reveals seal behavior
6. Nanotechnology helps scientists make bendy sensors for hydrogen vehicles
7. FDA Nanotechnology Task Force takes positive step forward
8. Liverpool amongst first in UK to install unique DNA sequencing technology
9. EPA foregoes opportunity to improve nanotechnology oversight
10. The Cancer Genome Atlas awards funds for technology development
11. Autism theory put to the test with new technology

Post Your Comments:
(Date:7/25/2014)... a pleiotropic factor characterized by the existence of ... that confer to the protein deeply different characteristics. ... myelination occurring during development and the different phases ... degeneration, axon regrowth, remyelination and target reinnervation, Researchers ... that the soluble NRG1 upregulation observed in Schwann ...
(Date:7/25/2014)... of a molecular testing panel developed at UPMC ... initial surgery for patients with thyroid nodules and ... Cancer Institute (UPCI), partner with UPMC CancerCenter., The ... and other diagnostic testing agencies, improved the chances ... 30 percent, according to the study published this ...
(Date:7/24/2014)... -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") announced the ... Phase 3 study of Zerenex (ferric citrate), the Company,s ... of hyperphosphatemia in patients with end-stage renal disease (ESRD) ... delivery with FErric CiTrate in EsrD) was published online ... of Nephrology ( JASN ). , ...
Breaking Biology News(10 mins):Test increases odds of correct surgery for thyroid cancer patients 2Test increases odds of correct surgery for thyroid cancer patients 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 4
(Date:7/24/2014)... MENLO PARK, Calif. , July 24, 2014 ... biotechnology company in the emerging field of regenerative ... live webcast of a presentation to investors on ... 1:30 p.m. PDT.  The presentation will include an ... pipeline. To access the webcast, visit http://www.ustream.tv/channel/asterias-biotherapeutics ...
(Date:7/24/2014)... Yet, scientists are making progress in devising suitable ... approach relies on quantum dotsa kind of artificial ... A new study demonstrates that changing the coupling ... electrical impulses can help better control them. This ... as quantum information units, which would produce faster ...
(Date:7/24/2014)... 24, 2014 Research and Markets ... and Proteomics Analytical Instruments Market 2014-2018" report to ... Genomics is the study of the gene ... the structure and functions of proteomes or sets of ... technology. Genomics involves the mapping of genes and DNA ...
(Date:7/24/2014)... Three companies from the angelMD network were ... Competition. Out of 700 competition entrants, Chiron Health, Litesprite, ... round. In this round twenty teams are invited to ... mentoring from thought-leaders and medical entrepreneurs from all over ... commitment to the Livestrong vision around the Big C ...
Breaking Biology Technology:Asterias Biotherapeutics Announces Live Investor Webcast 2Asterias Biotherapeutics Announces Live Investor Webcast 3Asterias Biotherapeutics Announces Live Investor Webcast 4Global Genomics and Proteomics Analytical Instruments Market 2014-2018: Key Vendors are Agilent, Bio-Rad , F. Hoffmann, La Roche, Illumina, PerkinElmer and Thermo Fisher Scientific 23 angelMD Startups Make Livestrong Big C Semi-finals 2
Cached News: